NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review

This publication has 49 references indexed in Scilit:

• An Association between Idiopathic Parkinson's Disease and Polymorphisms of Phase II Detoxification Enzymes: Glutathione S-Transferase M1 and Quinone Oxidoreductase 1 and 2
  Biochemical and Biophysical Research Communications, 2001
• Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes
  Journal of Human Genetics, 2001
• NRH:quinone oxidoreductase2 (NQO2)
  Published by Elsevier ,2001
• Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci
  Carcinogenesis: Integrative Cancer Research, 1999
• REGULATION OF GENE EXPRESSION BY REACTIVE OXYGEN
  Annual Review of Pharmacology and Toxicology, 1999
• Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies
  Pharmacogenetics, 1997
• Metabolic basis of benzene toxicity
  European Journal of Haematology, 1996
• Overview of benzene‐induced aplastic anaemia
  European Journal of Haematology, 1996
• Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect
  The Lancet, 1996
• Benzene Metabolism by Reconstituted Cytochromes P450 2B1 and 2E1 and Its Modulation by Cytochrome b5, Microsomal Epoxide Hydrolase, and Glutathione Transferases: Evidence for an Important Role of Microsomal Epoxide Hydrolase in the Formation of Hydroquinone
  Toxicology and Applied Pharmacology, 1993